Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer.

Kentaro Sudo,Takeshi Ishihara,Nobuto Hirata,Fumiaki Ozawa,Tadashi Ohshima,Ryosaku Azemoto,Kenji Shimura,Takeshi Nihei,Takayoshi Nishino,Akihiko Nakagawa,Kazuyoshi Nakamura,Taro Hara,Motohisa Tada,Rintaro Mikata,Katsunobu Tawada,Osamu Yokosuka,So Nakaji,Taketo Yamaguchi

Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer.

2014

Kentaro Sudo
Takeshi Ishihara
Nobuto Hirata
Fumiaki Ozawa
Tadashi Ohshima
Ryosaku Azemoto
Kenji Shimura
Takeshi Nihei
Takayoshi Nishino
Akihiko Nakagawa
Kazuyoshi Nakamura
Taro Hara
Motohisa Tada
Rintaro Mikata
Katsunobu Tawada
Osamu Yokosuka
So Nakaji
Taketo Yamaguchi

Purpose The aim of this study was to evaluate efficacy and safety of gemcitabine plus S-1 (GS) combination chemotherapy in patients with unresectable pancreatic cancer.

Keywords:

Randomized controlled trial
Pancreatic cancer
Gemcitabine
Oncology
Unresectable Pancreatic Cancer
Medicine
Internal medicine
Chemotherapy
combination chemotherapy
in patient
pharmacology toxicology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations